NewcelX

NewcelX Receivables

Accounts Receivable of NewcelX (NCEL) as of Nov 7, 2026.

Receivables

-USD

Last updated:

Accounts Receivable of NewcelX is 2026 - USD. Accounts Receivable of NewcelX was 2025 - USD. It decreases by % lower compared to the previous year.

The NewcelX Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2018
0.00 USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
The NewcelX Receivables history
YEARReceivablesYoY
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NewcelX Stock analysis

What does NewcelX do? NewcelX AG, based in Zurich, Switzerland, operates in the Health Care sector with a focus on Pharmaceuticals. The company, listed on 29 January 2021, develops therapeutics for neurobehavioral and neurocognitive disorders. With a small team of two employees, it serves customers globally, concentrating on innovative treatments for neurological conditions. NewcelX is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NewcelX stock

On Eulerpool you can find the complete historical development of Accounts Receivable NewcelX since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's NewcelX historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — NewcelX

All Key Metrics — NewcelX